Skip to content
drillr.ai
Sign up

002262.SZ

恩华药业

SZSE · Healthcare · C 制造业 · CN

CNY 21.85
−0.46%
Ask drillr

  • Aug 28, 2026, 03:46 UTC

    Nhwa Pharmaceutical obtained the Drug Registration Certificate for Brexpiprazole tablets approved by the National Medical Products Administration; the drug is used to treat adult schizophrenia.

    Source:

  • Aug 17, 2026, 10:34 UTC

    Enhua Pharmaceutical announced its first-half 2026 results: revenue of 3.218 billion yuan, up 6.91% year-on-year; net profit attributable to shareholders of 741 million yuan, up 5.74%; non-recurring-adjusted net profit of 746 million yuan, up 6.65%. The company plans no cash dividend, no bonus shares, and no capital reserve conversion.

    Source:

  • Aug 6, 2026, 02:36 UTC

    Shanghai Guotou Xiandao, Enhua Pharmaceutical, and Baili Tianheng (Shanghai) Biomedical Technology Co., Ltd. jointly invested about 217 million yuan to establish a venture capital fund, Shanghai Defu Venture Capital Fund Partnership (Limited Partnership), in Shanghai, for investing in unlisted enterprises.

    Source: